S&P 500 Futures
(-0.04%) 5 243.25 points

Dow Jones Futures
(-0.01%) 39 557 points

Nasdaq Futures
(-0.11%) 18 276 points

Oil
(-0.01%) $79.11

Gas
(-0.80%) $2.36

Gold
(0.19%) $2 347.40

Silver
(0.34%) $28.54

Platinum
(0.07%) $1 011.50

USD/EUR
(0.15%) $0.928

USD/NOK
(0.11%) $10.82

USD/GBP
(0.37%) $0.799

USD/RUB
(-0.37%) $91.26

Realtime updates for Albireo Pharma Inc [ALBO]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Last Updated2 Mar 2023 @ 16:00

25% discount on Stockinvest.us - Use code: Podcast

0.00% $ 44.15

Live Chart Being Loaded With Signals

Commentary (2 Mar 2023 @ 16:00):

Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders...

Stats
Today's Volume	1.24M
Average Volume	566 901
Market Cap	915.89M
EPS	$0 ( 2023-05-15 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-6.63
ATR14	$0.932 (2.11%)

Insider Trading

Date	Person	Action	Amount	type
2023-03-02	Chiswell David	Sell	56 278	Common Stock
2023-03-02	Chiswell David	Sell	8 000	Stock Option (Right to Buy)
2023-03-02	Chiswell David	Sell	8 000	Stock Option (Right to Buy)
2023-03-02	Chiswell David	Sell	8 000	Stock Option (Right to Buy)
2023-03-02	Chiswell David	Sell	5 500	Stock Option (Right to Buy)

INSIDER POWER
-50.19
Last 100 transactions
Buy: 1 059 000 \| Sell: 2 762 067

Volume Correlation

Long: 0.36 (neutral)

Short: 0.10 (neutral)

Signal:(68.034) Neutral

Albireo Pharma Inc Correlation

10 Most Positive Correlations
WPRT	0.988
RESN	0.98
RXDX	0.977
RETA	0.972
CSII	0.965
PATI	0.963
VREX	0.963
ZGNX	0.962
FLMN	0.961
ADMS	0.96

10 Most Negative Correlations
AAON	-0.975
EYE	-0.975
THRX	-0.969
IEP	-0.962
APLS	-0.96
PINC	-0.956
PEBK	-0.956
VRAR	-0.952
NVCT	-0.948
UNAM	-0.947

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Albireo Pharma Inc Correlation - Currency/Commodity

-0.28
( neutral )

-0.60
( weak negative )

-0.23
( neutral )

0.56
( weak )

-0.81
( strong negative )

0.31
( neutral )

Albireo Pharma Inc Financials

Annual	2021
Revenue:	$40.58M
Gross Profit:	$39.22M (96.66 %)
EPS:	$-1.770

FY	2021
Revenue:	$40.58M
Gross Profit:	$39.22M (96.66 %)
EPS:	$-1.770

FY	2020
Revenue:	$8.31M
Gross Profit:	$0.00 (0.00 %)
EPS:	$-6.73

FY	2019
Revenue:	$9.64M
Gross Profit:	$0.00 (0.00 %)
EPS:	$-5.04

Financial Reports:

No articles found.

Albireo Pharma Inc

Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as well as in Phase III clinical trial for treating biliary atresia, alagille syndrome, and rare and life-threatening disorder to children; and Elobixibat for the treatment of chronic constipation and other functional diseases. It also engages in the developing of A3907, which is in Phase I clinical trial for the treatment of adult liver diseases; and A2342, a preclinical candidate to treat adult viral and liver diseases. The company has a license agreement with EA Pharma Co., Ltd. for the development and commercialization of elobixibat. Albireo Pharma, Inc. is headquartered in Boston, Massachusetts.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Investing in the stock market involves risk and the value of your investment can fluctuate. The stock market can be affected by a variety of factors, including economic conditions, company performance, and global events. There is no guarantee of profit and you could lose money. Please consider your financial situation, investment goals, and level of risk tolerance before making any investment decisions. Consult with a financial advisor for personalized advice.